Rights and permissions
About this article
Cite this article
Enoxaparin a cost-effective choice for acute PE. Pharmacoecon. Outcomes News 488, 7 (2005). https://doi.org/10.2165/00151234-200504880-00019
Published:
Issue Date:
DOI: https://doi.org/10.2165/00151234-200504880-00019